Ken Griffin Renalytix PLC Call Options Transaction History
Citadel Advisors LLC
- $483 Billion
- Q2 2024
Call Options
5 transactions
Others Institutions Holding RNLX
# of Institutions
29Shares Held
3.72MCall Options Held
0Put Options Held
0-
Pinnacle Associates LTD815KShares$171,2390.0% of portfolio
-
Stifel Financial Corp St. Louis, MO561KShares$117,8100.0% of portfolio
-
Levin Capital Strategies, L.P. New York, NY555KShares$116,5500.01% of portfolio
-
Tejara Capital LTD London, X0500KShares$105,0820.04% of portfolio
-
Ci Private Wealth, LLC Miami, FL336KShares$70,4570.0% of portfolio
About Renalytix plc
- Ticker RNLX
- Exchange OTC
- Sector Healthcare
- Industry Health Information Services
- Shares Outstandng 37,445,900
- Market Cap $7.86M
- Description
- Renalytix Plc develops artificial intelligence-enabled in vitro diagnostic solutions for kidney diseases. The company offers KidneyIntelX, a diagnostic platform that employs an artificial intelligence-enabled algorithm that combines various data inputs, including validated blood-based biomarkers, inherited genetics and personalized patient data ...